METHOD AND SYSTEM FOR TREATING STRETCH MARKS
First Claim
1. An ultrasound system configured for treating stretch marks comprising:
- a control system configured for control of said ultrasound treatment system;
an imaging system coupled to said control system, said imaging system configured for imaging of a region of interest, said region of interest comprising at least one of an epidermis, a dermis, a deep dermis, and a fibrous fascia;
an ultrasound probe configured for generating a conformal lesion within said region of interest to facilitate substantial elimination of stretch marks, said control system and said probe being configured to operate in a frequency range of about 2 MHz to about 50 MHz.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods and systems for treating stretch marks through deep tissue tightening with ultrasound are provided. An exemplary method and system comprise a therapeutic ultrasound system configured for providing ultrasound treatment to a shallow tissue region, such as a region comprising an epidermis, a dermis and a deep dermis. In accordance with various exemplary embodiments, a therapeutic ultrasound system can be configured to achieve depth from 0 mm to 1 cm with a conformal selective deposition of ultrasound energy without damaging an intervening tissue in the range of frequencies from 2 to 50 MHz. In addition, a therapeutic ultrasound can also be configured in combination with ultrasound imaging or imaging/monitoring capabilities, either separately configured with imaging, therapy and monitoring systems or any level of integration thereof.
-
Citations
27 Claims
-
1. An ultrasound system configured for treating stretch marks comprising:
-
a control system configured for control of said ultrasound treatment system;
an imaging system coupled to said control system, said imaging system configured for imaging of a region of interest, said region of interest comprising at least one of an epidermis, a dermis, a deep dermis, and a fibrous fascia;
an ultrasound probe configured for generating a conformal lesion within said region of interest to facilitate substantial elimination of stretch marks, said control system and said probe being configured to operate in a frequency range of about 2 MHz to about 50 MHz. - View Dependent Claims (2, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
-
- 4. The ultrasound system of claim 4, wherein said temporal control comprises selection of one or more temporal parameters comprising drive amplitude levels, frequency/waveforms, and timing sequences.
-
17. A method for treating stretch marks, said method comprising:
-
selecting a probe configuration based on a spatial and a temporal parameter;
imaging a treatment region comprising at least one of an epidermis, a dermis, a deep dermis, and a fibrous fascia;
verifying said temporal and said spatial parameters of said probe;
confirming acoustic coupling of said probe to said treatment region; and
applying ultrasound energy to ablate a portion of said treatment region to facilitate treatment stretch marks. - View Dependent Claims (18, 19, 20, 21)
-
-
22. An ultrasound system configured for treating stretch marks comprising:
-
a control system configured for control of said ultrasound treatment system;
an imaging system coupled to said control system, said imaging system configured for imaging at least one of an epidermis, a dermis, a deep dermis, and a fibrous fascia;
an ultrasound probe configured for generating a conformal lesion within said region of interest to facilitate treatment of stretch marks, said control system and said ultrasound probe being configured for spatial and temporal control to generate said conformal lesion. - View Dependent Claims (23, 24, 25, 26)
-
-
27. A method for providing treatment of stretch marks, said method comprising:
-
localizing of at least one of an epidermis, a dermis, a deep dermis, and a fibrous fascia within a region of interest;
targeting of delivery of ablative ultrasound energy from a transducer probe to said at least one of said epidermis, said dermis, said deep dermis, and said fibrous fascia; and
monitoring of results of said targeted delivery within said at least one of said epidermis, said dermis, said deep dermis, and said fibrous fascia during and after said targeted delivery to continue planning of treatment.
-
Specification